Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Christopher Richard Anzalone. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Christopher Richard Anzalone har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ARWR / Arrowhead Pharmaceuticals, Inc. Chief Executive Officer, Director 3.921.255
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Christopher Richard Anzalone. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Christopher Richard Anzalone som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-04-11 2025-04-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -50.800 3.921.255 -1,28 11,49 -583.692 45.055.220
2025-04-11 2025-04-10 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -50.000 3.972.055 -1,24 10,87 -543.500 43.176.238
2025-04-11 2025-04-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.617 4.022.055 -0,04 11,76 -19.016 47.299.367
2025-04-11 2025-04-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -3.400 4.023.672 -0,08 10,75 -36.550 43.254.474
2025-04-11 2025-04-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -35.305 4.027.072 -0,87 9,93 -350.579 39.988.825
2025-03-17 2025-03-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -51.425 4.062.377 -1,25 15,07 -774.975 61.220.021
2025-03-17 2025-03-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 340.000 4.113.802 9,01
2025-03-05 2025-03-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -133.333 3.773.802 -3,41 17,02 -2.269.328 64.230.110
2025-03-05 2025-03-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 133.333 4.073.802 3,38 7,75 1.033.331 31.571.966
2025-03-05 2025-03-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -166.667 3.907.135 -4,09 18,03 -3.005.006 70.445.644
2025-03-05 2025-03-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 166.667 3.940.469 4,42 7,75 1.291.669 30.538.635
2025-02-10 2025-02-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 9.550 3.773.802 0,25 20,10 191.955 75.853.420
2025-01-06 2025-01-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11.520 3.764.252 -0,31 19,05 -219.456 71.709.001
2024-12-23 2024-12-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12.563 3.775.772 -0,33 19,59 -246.109 73.967.373
2024-12-20 2024-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 100.000 3.788.335 2,71
2024-12-20 2024-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.799 3.688.335 -0,16 22,12 -128.274 81.585.970
2024-12-20 2024-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.260 3.694.134 -0,22 21,74 -179.572 80.310.473
2024-12-20 2024-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12.653 3.702.394 -0,34 20,52 -259.640 75.973.125
2024-02-02 2024-01-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -19.730 3.715.048 -0,53 32,71 -645.368 121.519.220
2024-02-02 2024-01-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -37.769 3.734.778 -1,00 32,16 -1.214.651 120.110.460
2024-02-02 2024-01-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 57.499 3.772.547 1,55 14,54 836.035 54.852.833
2024-01-04 2024-01-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.318 3.715.048 -0,14 31,25 -166.188 116.095.250
2024-01-04 2024-01-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.634 3.720.366 -0,12 30,74 -142.449 114.364.051
2023-12-22 2023-12-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12.000 3.725.000 -0,32 28,54 -342.480 106.311.500
2023-10-27 2023-10-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -24.338 3.737.000 -0,65 24,21 -589.223 90.472.770
2023-09-20 2023-09-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -26.232 3.761.338 -0,69 28,27 -741.579 106.333.025
2023-09-20 2023-09-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -31.523 3.787.570 -0,83 28,00 -882.644 106.051.960
2023-09-20 2023-09-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 57.755 3.819.093 1,54 4,75 274.336 18.140.692
2023-05-05 2023-05-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -25.992 3.761.338 -0,69 40,02 -1.040.200 150.528.747
2023-05-05 2023-05-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -24.008 3.787.330 -0,63 38,97 -935.592 147.592.250
2023-05-05 2023-05-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 50.000 3.811.338 1,33 2,01 100.500 7.660.789
2023-05-05 2023-05-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -54.928 3.761.338 -1,44 39,14 -2.149.882 147.218.769
2023-05-05 2023-05-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 54.928 3.816.266 1,46 2,01 110.405 7.670.695
2022-12-20 2022-12-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 234.025 3.720.714 6,71
2022-12-20 2022-12-16 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 18.375 3.486.689 0,53
2022-09-29 2022-09-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise X -1.542 3.468.314 -0,04 31,21 -48.126 108.246.080
2022-09-29 2022-09-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise X -39.082 3.469.856 -1,11 30,77 -1.202.553 106.767.469
2022-07-12 2022-07-08 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
D - Sale to Issuer -551.197 3.508.938 -13,58
2022-07-11 2022-07-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.501 4.060.135 0,06 14,54 36.365 59.034.363
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy Common Stock)
M - Exercise -146.388 615.033 -19,23
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.900 4.057.634 -0,05 50,51 -95.969 204.951.093
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -61.482 4.059.534 -1,49 50,90 -3.129.434 206.630.281
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -42.153 4.121.016 -1,01 52,28 -2.203.759 215.446.716
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -40.853 4.163.169 -0,97 53,11 -2.169.703 221.105.906
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 146.388 4.204.022 3,61 5,19 759.754 21.818.874
2022-01-07 2022-01-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy Common Stock)
M - Exercise -11.806 761.421 -1,53
2022-01-07 2022-01-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11.806 4.057.634 0,29 5,19 61.273 21.059.120
2022-01-04 2022-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 800.000 4.045.828 24,65
2021-12-23 2021-12-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy Common Stock)
M - Exercise -11.806 773.227 -1,50
2021-12-23 2021-12-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11.806 3.245.828 0,37 5,19 61.273 16.845.847
2021-12-17 2021-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.989 3.219.022 -0,22 70,19 -490.558 225.943.154
2021-12-17 2021-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9.223 3.226.011 -0,29 69,52 -641.183 224.272.285
2021-12-17 2021-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.074 3.235.234 -0,09 68,20 -209.647 220.642.959
2021-12-17 2021-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14.857 3.238.308 -0,46 67,19 -998.242 217.581.915
2021-12-17 2021-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -25.857 3.253.165 -0,79 66,28 -1.713.802 215.619.776
2021-10-22 2021-10-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.830 3.279.022 -0,18 66,09 -385.305 216.710.564
2021-10-22 2021-10-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -44.170 3.284.852 -1,33 65,57 -2.896.227 215.387.746
2021-10-22 2021-10-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15.000 3.329.022 -0,45 66,23 -993.450 220.481.127
2021-01-04 2021-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 800.000 3.344.022 31,45
2021-01-04 2020-12-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -599 2.544.022 -0,02
2020-12-30 2020-12-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -1.126 2.544.621 -0,04
2020-12-22 2020-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock (right to buy)
M - Exercise -28.274 800.033 -3,41
2020-12-22 2020-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock (right to buy)
M - Exercise -12.236 828.307 -1,46
2020-12-22 2020-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 28.274 2.545.747 1,12 6,15 173.885 15.656.344
2020-12-22 2020-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 12.236 2.517.473 0,49 4,75 58.121 11.957.997
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -38.676 840.543 -4,40
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -4.003 2.505.237 -0,16 71,61 -286.655 179.400.022
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -5.880 2.509.240 -0,23 70,87 -416.716 177.829.839
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -12.067 2.515.120 -0,48 69,80 -842.277 175.555.376
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -16.726 2.527.187 -0,66 67,27 -1.125.158 170.003.869
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 38.676 2.543.913 1,54 2,01 77.739 5.113.265
2020-12-10 2020-12-08 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -16.324 879.219 -1,82
2020-12-10 2020-12-08 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -16.324 2.505.237 -0,65 67,97 -1.109.542 170.280.959
2020-12-10 2020-12-08 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 16.324 2.521.561 0,65 2,01 32.811 5.068.338
2020-10-23 2020-10-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12.272 2.505.237 -0,49 58,57 -718.771 146.731.731
2020-10-23 2020-10-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -87.728 2.517.509 -3,37 58,16 -5.102.260 146.418.323
2020-08-14 2020-08-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -50.000 895.543 -5,29
2020-08-14 2020-08-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -50.000 2.605.237 -1,88 41,35 -2.067.500 107.726.550
2020-08-14 2020-08-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 50.000 2.655.237 1,92 9,90 495.000 26.286.846
2020-06-26 2020-06-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -23 2.605.237 0,00 39,55 -910 103.037.123
2020-06-26 2020-06-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -99.977 2.605.260 -3,70 38,81 -3.880.107 101.110.141
2020-01-03 2020-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 900.000 2.705.237 49,85
2019-12-27 2019-12-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -83.333 1.805.237 -4,41 63,50 -5.291.646 114.632.550
2019-12-13 2019-12-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.393 1.888.570 -0,18 68,18 -231.335 128.762.703
2019-12-13 2019-12-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -25.412 1.891.963 -1,33 67,30 -1.710.228 127.329.110
2019-12-13 2019-12-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -45.577 1.917.375 -2,32 66,47 -3.029.503 127.447.916
2019-12-13 2019-12-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.951 1.962.952 -0,45 65,85 -589.423 129.260.389
2019-12-13 2019-12-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.379 1.971.903 -0,42 69,41 -581.586 136.869.787
2019-12-13 2019-12-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10.343 1.980.282 -0,52 68,51 -708.599 135.669.120
2019-12-13 2019-12-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -58.059 1.990.625 -2,83 67,31 -3.907.951 133.988.969
2019-12-13 2019-12-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -23.219 2.048.684 -1,12 66,82 -1.551.494 136.893.065
2019-12-04 2019-12-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.022 2.071.903 -0,39 62,00 -497.364 128.457.986
2019-12-04 2019-12-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.011 2.079.925 -0,19 60,73 -243.588 126.313.845
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.656 2.083.936 -0,18 72,95 -266.705 152.023.131
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.800 2.087.592 -0,18 72,13 -274.094 150.578.011
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.448 2.091.392 -0,12 70,72 -173.123 147.903.242
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.617 2.093.840 -0,32 69,50 -459.882 145.521.880
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.510 2.100.457 -0,40 68,50 -582.935 143.881.304
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.193 2.108.967 -0,34 67,63 -486.463 142.629.438
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.743 2.116.160 -0,27 66,58 -382.369 140.893.933
2019-10-11 2019-10-10 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -56.325 945.543 -5,62
2019-10-11 2019-10-10 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -56.325 2.121.903 -2,59 31,83 -1.792.825 67.540.172
2019-10-11 2019-10-10 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 56.325 2.178.228 2,65 5,20 292.890 11.326.786
2019-09-27 2019-09-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -20.000 2.121.903 -0,93 28,25 -565.000 59.943.760
2019-09-24 2019-09-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -66.645 1.001.868 -6,24
2019-09-24 2019-09-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -12.673 2.141.903 -0,59 29,04 -368.024 62.200.863
2019-09-24 2019-09-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -53.972 2.154.576 -2,44 28,00 -1.511.216 60.328.128
2019-09-24 2019-09-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 66.645 2.208.548 3,11 5,10 339.890 11.263.595
2019-09-24 2019-09-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -41.755 1.068.513 -3,76
2019-09-24 2019-09-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -41.755 2.141.903 -1,91 29,04 -1.212.565 62.200.863
2019-09-24 2019-09-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 41.755 2.183.658 1,95 5,10 212.950 11.136.656
2019-09-24 2019-09-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -4.250 1.110.268 -0,38
2019-09-24 2019-09-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -4.250 2.141.903 -0,20 29,00 -123.250 62.115.187
2019-09-24 2019-09-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.250 2.146.153 0,20 5,10 21.675 10.945.380
2019-05-29 2019-05-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -9.376 1.133.418 -0,82
2019-05-29 2019-05-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -40.072 1.142.794 -3,39
2019-05-29 2019-05-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9.376 2.141.903 0,44 2,62 24.565 5.611.786
2019-05-29 2019-05-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 40.072 2.132.527 1,92 2,01 80.545 4.286.379
2019-04-05 2019-04-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -50.000 2.092.455 -2,33 19,30 -965.000 40.384.382
2019-01-03 2019-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 600.000 2.142.455 38,90
2018-12-21 2018-12-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -90.000 1.542.455 -5,51 13,92 -1.252.800 21.470.974
2018-12-14 2018-12-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common STock
S - Sale X -90.000 1.632.455 -5,23 14,07 -1.266.300 22.968.642
2018-11-09 2018-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.300 1.722.455 -0,31 14,95 -79.235 25.750.702
2018-11-09 2018-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -76.200 1.727.755 -4,22 14,35 -1.093.470 24.793.284
2018-09-05 2018-09-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -64.834 1.803.955 -3,47 14,45 -936.851 26.067.150
2018-09-05 2018-08-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100.000 1.868.789 -5,08 14,45 -1.445.000 27.004.001
2018-03-16 2018-03-16 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -26.000 1.968.789 -1,30 7,40 -192.400 14.569.039
2018-03-15 2018-03-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100.000 1.994.789 -4,77 7,41 -741.000 14.781.386
2018-03-15 2018-03-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100.000 2.094.789 -4,56 7,44 -744.000 15.585.230
2018-03-15 2018-03-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100.000 2.194.789 -4,36 7,43 -743.000 16.307.282
2018-01-03 2018-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 500.000 2.294.789 27,86
2017-04-14 2017-04-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 978.000 1.794.789 119,74
2016-12-15 2016-12-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
F - Taxes -300.444 816.789 -26,89 1,27 -381.564 1.037.322
2016-07-05 2016-06-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock Warrant
X - Other -15.772 0 -100,00
2016-07-05 2016-06-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 15.772 1.117.233 1,43 5,09 80.279 5.686.716
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Stock Options
A - Award 80.000 1.166.466 7,36
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 540.000 1.101.461 96,18
2016-01-04 2015-12-30 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
F - Taxes -58.712 561.461 -9,47 6,13 -359.905 3.441.756
2015-03-06 2015-03-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Options
A - Award 300.000 1.086.466 38,15
2015-03-06 2015-03-04 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 360.000 620.173 138,37
2014-10-15 2014-10-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
P - Purchase 16.000 260.173 6,55 6,32 101.120 1.644.293
2014-10-15 2014-10-15 4/A ARWR ARROWHEAD RESEARCH CORP
Common Stock
P - Purchase 16.000 260.173 6,55 6,32 101.120 1.644.293
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Options
A - Award 60.000 786.466 8,26
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 210.000 244.173 614,52
2013-09-24 2013-09-21 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 69.991 726.466 10,66
2013-05-08 2013-05-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 200.000 656.475 43,81
2012-10-02 2012-09-28 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 50.000 456.475 12,30
2012-02-21 2012-02-16 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 170.000 406.475 71,89
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)